|
Quotes & Info
|
| IMUC > SEC Filings for IMUC > Form 8-K on 2-Jan-2013 | All Recent SEC Filings |
2-Jan-2013
Change in Directors or Principal Officers
On December 28, 2012, the Board of Directors of ImmunoCellular Therapeutics, Ltd. (the "Company") appointed Gary Titus as a member of the Company's Board of Directors, effective immediately. A copy of the press release announcing Mr. Titus' appointment is attached as Exhibit 99.1.
|
|